공고 • Jun 30
Xinjiang Tianye Co., Ltd. to Report First Half, 2026 Results on Aug 22, 2026 Xinjiang Tianye Co., Ltd. announced that they will report first half, 2026 results on Aug 22, 2026 Board Change • May 20
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hui Wei was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. 공고 • Apr 10
Xinjiang Tianye Co.,Ltd., Annual General Meeting, May 20, 2026 Xinjiang Tianye Co.,Ltd., Annual General Meeting, May 20, 2026, at 12:00 China Standard Time. Location: 9F, Office Building, No. 36, Beisan East Road, Shihezi Economic and Technological Development Zone, Xinjiang China 공고 • Mar 30
Xinjiang Tianye Co.,Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Xinjiang Tianye Co.,Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 공고 • Dec 26
Xinjiang Tianye Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 10, 2026 Xinjiang Tianye Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 10, 2026 공고 • Sep 30
Xinjiang Tianye Co.,Ltd. to Report Q3, 2025 Results on Oct 25, 2025 Xinjiang Tianye Co.,Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025 공고 • Jun 30
Xinjiang Tianye Co.,Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Xinjiang Tianye Co.,Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 공고 • Apr 10
Xinjiang Tianye Co.,Ltd., Annual General Meeting, May 16, 2025 Xinjiang Tianye Co.,Ltd., Annual General Meeting, May 16, 2025, at 12:00 China Standard Time. Location: 9F, Office Building, No. 36, Beisan East Road, Shihezi Economic and Technological Development Zone, Xinjiang China 공고 • Mar 28
Xinjiang Tianye Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Xinjiang Tianye Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 공고 • Dec 27
Xinjiang Tianye Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 10, 2025 Xinjiang Tianye Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 10, 2025 Reported Earnings • Oct 23
Third quarter 2024 earnings released: EPS: CN¥0.002 (vs CN¥0.12 loss in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.002 (up from CN¥0.12 loss in 3Q 2023). Revenue: CN¥2.59b (down 4.4% from 3Q 2023). Net income: CN¥3.40m (up CN¥196.6m from 3Q 2023). Profit margin: 0.1% (up from net loss in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. 공고 • Sep 30
Xinjiang Tianye Co.,Ltd. to Report Q3, 2024 Results on Oct 23, 2024 Xinjiang Tianye Co.,Ltd. announced that they will report Q3, 2024 results on Oct 23, 2024 Reported Earnings • Aug 22
Second quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.32 loss in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.11 (up from CN¥0.32 loss in 2Q 2023). Revenue: CN¥2.98b (down 13% from 2Q 2023). Net income: CN¥179.8m (up CN¥728.4m from 2Q 2023). Profit margin: 6.0% (up from net loss in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. 공고 • Jun 28
Xinjiang Tianye Co.,Ltd. to Report First Half, 2024 Results on Aug 22, 2024 Xinjiang Tianye Co.,Ltd. announced that they will report first half, 2024 results on Aug 22, 2024 Reported Earnings • Apr 23
First quarter 2024 earnings released: CN¥0.10 loss per share (vs CN¥0.07 loss in 1Q 2023) First quarter 2024 results: CN¥0.10 loss per share (further deteriorated from CN¥0.07 loss in 1Q 2023). Revenue: CN¥2.23b (down 21% from 1Q 2023). Net loss: CN¥173.1m (loss widened 45% from 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Apr 17
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 2.0% to CN¥4.08. The fair value is estimated to be CN¥3.36, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. 공고 • Apr 03
Xinjiang Tianye Co.,Ltd., Annual General Meeting, Apr 23, 2024 Xinjiang Tianye Co.,Ltd., Annual General Meeting, Apr 23, 2024, at 12:00 China Standard Time. Location: The Company's Meeting Room, Shihezi, Xinjiang China Buy Or Sell Opportunity • Mar 29
Now 21% overvalued Over the last 90 days, the stock has fallen 6.9% to CN¥4.02. The fair value is estimated to be CN¥3.33, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making. 공고 • Mar 29
Xinjiang Tianye Co.,Ltd. to Report Q1, 2024 Results on Apr 20, 2024 Xinjiang Tianye Co.,Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024 Reported Earnings • Mar 23
Full year 2023 earnings released: CN¥0.45 loss per share (vs CN¥0.50 profit in FY 2022) Full year 2023 results: CN¥0.45 loss per share (down from CN¥0.50 profit in FY 2022). Revenue: CN¥11.5b (down 1.6% from FY 2022). Net loss: CN¥775.4m (down 191% from profit in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 55 percentage points per year, which is a significant difference in performance. 공고 • Feb 20
Xinjiang Tianye Co.,Ltd. (SHSE:600075) announces an Equity Buyback for CNY 150 million worth of its shares. Xinjiang Tianye Co.,Ltd. (SHSE:600075) announces a share repurchase program. Under the program, the company will repurchase up to CNY 150 million worth of its shares. The authorization will be valid for a period of 12 months. New Risk • Feb 01
New major risk - Revenue and earnings growth Earnings have declined by 1.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Cash payout ratio: 119% Earnings have declined by 1.8% per year over the past 5 years. 공고 • Dec 29
Xinjiang Tianye Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 23, 2024 Xinjiang Tianye Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 23, 2024 Reported Earnings • Oct 31
Third quarter 2023 earnings released: CN¥0.12 loss per share (vs CN¥0.083 profit in 3Q 2022) Third quarter 2023 results: CN¥0.12 loss per share (down from CN¥0.083 profit in 3Q 2022). Revenue: CN¥2.71b (down 12% from 3Q 2022). Net loss: CN¥193.2m (down 251% from profit in 3Q 2022). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. New Risk • Aug 26
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 14% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Minor Risk Paying a dividend despite being loss-making. 공고 • Jun 27
Xinjiang Tianye Co.,Ltd. to Report First Half, 2023 Results on Aug 26, 2023 Xinjiang Tianye Co.,Ltd. announced that they will report first half, 2023 results on Aug 26, 2023 Reported Earnings • Apr 21
First quarter 2023 earnings released: CN¥0.02 loss per share (vs CN¥0.16 profit in 1Q 2022) First quarter 2023 results: CN¥0.02 loss per share (down from CN¥0.16 profit in 1Q 2022). Revenue: CN¥2.51b (down 15% from 1Q 2022). Net loss: CN¥39.3m (down 114% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 3% per year. Buying Opportunity • Feb 16
Now 21% undervalued Over the last 90 days, the stock is up 3.4%. The fair value is estimated to be CN¥7.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 25%. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Independent Director Ze Quan was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.083 (vs CN¥0.32 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.083 (down from CN¥0.32 in 3Q 2021). Revenue: CN¥3.08b (down 3.0% from 3Q 2021). Net income: CN¥127.6m (down 73% from 3Q 2021). Profit margin: 4.1% (down from 15% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Sep 17
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥7.41, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 33%. Revenue is forecast to grow by 0.9% in 2 years. Earnings is forecast to grow by 52% in the next 2 years. Reported Earnings • Aug 20
Second quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥0.36 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.27 (down from CN¥0.36 in 2Q 2021). Revenue: CN¥3.36b (up 24% from 2Q 2021). Net income: CN¥445.3m (down 11% from 2Q 2021). Profit margin: 13% (down from 19% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 6.0% compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 28
Investor sentiment deteriorated over the past week After last week's 21% share price decline to CN¥5.81, the stock trades at a trailing P/E ratio of 7.1x. Average trailing P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 1.2% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Independent Director Ze Quan was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.32 (vs CN¥0.24 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥3.17b (up 36% from 3Q 2020). Net income: CN¥473.2m (up 42% from 3Q 2020). Profit margin: 15% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥10.17, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 91% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.58 per share. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment improved over the past week After last week's 27% share price gain to CN¥11.64, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 127% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥18.36 per share. Valuation Update With 7 Day Price Move • Aug 28
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥9.92, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 76% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.46 per share. Reported Earnings • Aug 22
Second quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.062 in 2Q 2020) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: CN¥2.70b (down 6.9% from 2Q 2020). Net income: CN¥500.9m (up 359% from 2Q 2020). Profit margin: 19% (up from 3.8% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.024 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥2.51b (up 199% from 1Q 2020). Net income: CN¥465.7m (up CN¥442.5m from 1Q 2020). Profit margin: 19% (up from 2.8% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Feb 23
New 90-day high: CN¥7.45 The company is up 12% from its price of CN¥6.65 on 25 November 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Jan 11
New 90-day low: CN¥5.36 The company is down 25% from its price of CN¥7.12 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: CN¥5.81 The company is down 13% from its price of CN¥6.66 on 17 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. Reported Earnings • Oct 16
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥149.8m, down 72% from the prior year. Total revenue was CN¥5.36b over the last 12 months, down 16% from the prior year.